Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
about
Will the SAFE strategy be sufficient to eliminate trachoma by 2020? Puzzlements and possible solutionsThe Relationship between Active Trachoma and Ocular Chlamydia trachomatis Infection before and after Mass Antibiotic TreatmentShort-term forecasting of the prevalence of clinical trachoma: utility of including delayed recovery and tests for infectionDevelopment and evaluation of a next-generation digital PCR diagnostic assay for ocular Chlamydia trachomatis infections.The association between latrine use and trachoma: a secondary cohort analysis from a randomized clinical trialUsing a nonparametric multilevel latent Markov model to evaluate diagnostics for trachoma.
P2860
Diagnostic characteristics of tests for ocular Chlamydia after mass azithromycin distributions
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
2012年论文
@zh
2012年论文
@zh-cn
name
Diagnostic characteristics of ...... ass azithromycin distributions
@ast
Diagnostic characteristics of ...... ass azithromycin distributions
@en
type
label
Diagnostic characteristics of ...... ass azithromycin distributions
@ast
Diagnostic characteristics of ...... ass azithromycin distributions
@en
prefLabel
Diagnostic characteristics of ...... ass azithromycin distributions
@ast
Diagnostic characteristics of ...... ass azithromycin distributions
@en
P2093
P2860
P50
P356
P1476
Diagnostic characteristics of ...... ass azithromycin distributions
@en
P2093
Berhan Ayele
Charles E McCulloch
Craig W See
Jeanne Moncada
Julius Schachter
Paul M Emerson
Teshome Gebre
P2860
P304
P356
10.1167/IOVS.11-8493
P407
P577
2012-01-25T00:00:00Z